[AlaskaAngel]

At least one other potential solution for us remains in limbo.

I've been following the development and clinical trials for the use of ospemifene for many years now. I tried to get into a clinical trial for it, but could not because I'd had breast cancer. But it has been approved for general use for these problems. Interestingly, it, like tamoxifen, is a SERM.

I would think a SERM that could help with these issues logically could be a better choice than tamoxifen, but based on my attempt to participate in a clinical trial for ospemifene as a breast cancer patient, that doesn't seem to have been investigated thus far in our behalf, possibly on the usual basis that they don't want to put any of us at any additional risk simply to find better solutions for our care. I personally don't agree with that, although can understand if others prefer to minimize QOL to minimize risk. However, like the use of the E-string, it should still be available to those of us who are willing to try it.